Focus on Bridging Treatment Gaps
At Strongbridge Biopharma, our focus on rare diseases has resulted in a portfolio of innovative treatments for rare neuromuscular and endocrine conditions, including the commercialization of KEVEYIS in the U.S.
Committed to Positive Results
At Strongbridge Biopharma, we are committed to delivering better results for patients, healthcare providers, employees, and investors.
Passion for Compassion
The Strongbridge team is passionate about making a positive difference in the lives of patients with rare diseases. It’s why we’re here.